MARKET NEWS

Weight Loss Entrepreneurship Takes Off

By: Anneken Tappe · October 27, 2023 · Reading Time: 2 minutes

Capital Injection

Signos, a startup developing wearable sensors designed to track your metabolism, just raised $20 million from investors, led by Cheyenne Ventures and GV (GOOGL).

Signos’ raise adds to the recent weight loss craze, fueled by Novo Nordisk’s (NVO) popular weight loss drugs Ozempic and Wegovy.

How It Works

Signos wants to help you battle diabetes by using continuous glucose monitors, or CGMs, to track your glucose levels over time.

A small sensor effectively keeps track of your metabolism as you go about your day, and sends your health data directly to your phone. It also offers personalized, real-time advice on what to eat, and how to exercise.

Acting in the Moment

For people with diabetes or other health issues, real-time data can be invaluable when making dietary decisions. Signos takes diabetes treatment one step further by educating users about how their metabolisms work. Based on data from the sensor, the Signos app can show how the body responds to certain foods, what causes glucose to spike, and what time of day to work out for the best results.

Looking for more stories like this? Check out On the Money — SoFi’s one-stop-shop for news, trends, and tips!

Check it out

Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.
SOSS23102703

Terms and Conditions Apply. SOFI RESERVES THE RIGHT TO MODIFY OR DISCONTINUE PRODUCTS AND BENEFITS AT ANY TIME WITHOUT NOTICE. To qualify, a borrower must be a U.S. citizen or other eligible status and and meet SoFi's underwriting requirements. Not all borrowers receive the lowest rate. Lowest rates reserved for the most creditworthy borrowers. If approved, your actual rate will be within the range of rates listed above and will depend on a variety of factors, including term of loan, evaluation of your creditworthiness, years of professional experience, income, and a variety of other factors. Rates and Terms are subject to change at anytime without notice and are subject to state restrictions. SoFi refinance loans are private loans and do not have the same repayment options that the federal loan program offers, or may become available, such as Income Based Repayment or Income Contingent Repayment or PAYE. Licensed by the Department of Financial Protection and Innovation under the California Financing Law License No. 6054612. SoFi loans are originated by SoFi Lending Corp. or an affiliate, NMLS # 1121636. (www.nmlsconsumeraccess.org)

✝︎ To check the rates and terms you qualify for, SoFi conducts a soft credit pull that will not affect your credit score. However, if you choose a product and continue your application, we will request your full credit report from one or more consumer reporting agencies, which is considered a hard credit pull and may affect your credit.

©2024 Social Finance, LLC All rights reserved.
TLS 1.2 Encrypted
Equal Housing Lender